Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Pediatric Pulmonology|August 21, 2024
Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping reviewNatalie R Rose, S Garrison Dabbs, Emma C O'Hagan, et al.The European Respiratory Journal|July 2, 2026
Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosisJennifer S Guimbellot, Elizabeth Baker, Ashritha Chalamalla, et al.Pediatric Pulmonology|March 8, 2026
Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator TherapyJulianna Bailey, Natalie R Rose, Ashritha R Chalamalla, et al.Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|August 4, 2026
Shifting Nutrition Paradigms: Changing Attitudes Towards Diet and Body Perceptions Among People With CF in the Era of Highly Effective ModulatorsJulianna Bailey, Natalie R Rose, Leslie Pitts, et al.Pharmacotherapy|December 24, 2024
Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosisNatalie R Rose, Julianna Bailey, Justin D Anderson, et al.Pulmonary Pharmacology & Therapeutics|July 4, 2024
Differential distribution of ivacaftor and its metabolites in plasma and human airway epitheliaZhongyu Liu, Justin D Anderson, Natalie R Rose, et al.Pulmonary Pharmacology & Therapeutics|May 26, 2024
Pharmacokinetic variability of CFTR modulators from standard and alternative regimensNatalie R Rose, Ashritha R Chalamalla, Bryan A Garcia, et al.Pageof 1